深化药事管理现代化改革,赋能药学事业高质量发展

    Advancing Modernization Reform in Pharmaceutical Affairs Management to Catalyze High-Quality Development of Pharmacy Practice

    • 摘要: 药事管理是保障公众用药安全和促进医药产业高质量发展的关键支撑。随着药事管理内涵的持续深化,推进其现代化改革已成为时代的必然选择与发展趋势。鉴于此,本期特设“药事管理”专栏,围绕“药品监管与政策研究”“药品注册与审评审批”“药品流通与药事服务”及“医药产业与高效发展”4大主题开展研究。专栏将深入探讨监管制度创新、药事服务转型以及产业生态优化等关键议题,旨在为中国完善药事管理体系提供理论支撑与典型实践范例,从而更好地满足公众的健康需求,助力中国健康战略的全面实施。

       

      Abstract: Pharmaceutical affairs management is foundational for ensuring public medication safety and advancing high-quality pharmaceutical industry development. The continuous conceptual evolution of this field necessitates modernization reforms characterized by legal standardization, digital transformation, and global integration as a strategic imperative. This special issue establishes a dedicated Pharmaceutical Affairs Management column, focusing on 4 interconnected domains: regulatory policy innovation, drug registration systems, pharmaceutical service delivery, and industry advancement frameworks. Through rigorous examination of pivotal challenges, which include regulatory modernization, service model transformation, and industrial ecosystem optimization, this column aims to establish evidence-based governance frameworks, strengthen China's pharmaceutical safety governance capacity, and catalyze the transition from volume-driven growth to value-oriented development in pharmacy practice. These scholarly contributions ultimately support the comprehensive implementation of the Healthy China 2030 Initiative.

       

    /

    返回文章
    返回